The National Institute for Health and Care Excellence (NICE) has recommended obinutuzumab (Gazyvaro, Roche) in combination with mycophenolate mofetil for treating adults with active class 3 or 4 lupus ...
Belimumab can reduce the glucocorticoid burden in patients with lupus nephritis, real-world data show. A majority of real-world patients with lupus nephritis (LN) who start belimumab are able to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results